260 related articles for article (PubMed ID: 28225293)
21. Progressive multifocal leukoencephalopathy due to John Cunningham (JC) virus following allogeneic haematopoietic cell transplantation.
Lam W; Al-Shaibani Z; Kumar D; Viswabandya A; Thyagu S; Michelis FV; Kim DD; Lipton JH; Messner HA; Deotare U
Antivir Ther; 2017; 22(8):721-725. PubMed ID: 28362268
[TBL] [Abstract][Full Text] [Related]
22. Progressive multifocal leukoencephalopathy in patients with a hematological malignancy: review of therapeutic options.
Kalisch A; Wilhelm M; Erbguth F; Birkmann J
Chemotherapy; 2014; 60(1):47-53. PubMed ID: 25376181
[TBL] [Abstract][Full Text] [Related]
23. Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy.
Hsiehchen D; Arasaratnam R; Raj K; Froehlich T; Anderson L
Oncology; 2018; 95(5):319-322. PubMed ID: 30045034
[TBL] [Abstract][Full Text] [Related]
24. [Fatal neurological side effect of anti-CD20 antibody treatment].
Schmidt K; Skusa R; Großmann A
Inn Med (Heidelb); 2023 Feb; 64(2):193-196. PubMed ID: 36422661
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy complicating Waldenström's macroglobulinaemia.
Ng C; Slavin MA; Seymour JF
Leuk Lymphoma; 2003 Oct; 44(10):1819-21. PubMed ID: 14692541
[TBL] [Abstract][Full Text] [Related]
26. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.
Pejsa V; Lucijanic M; Jonjic Z; Prka Z; Vukorepa G
Ann Hematol; 2019 Jun; 98(6):1509-1510. PubMed ID: 30421169
[No Abstract] [Full Text] [Related]
27. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Paues J; Vrethem M
J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
[TBL] [Abstract][Full Text] [Related]
29. [Initial ophthalmic manifestation of a fatal underlying disease : Importance of perimetry in unspecific visual deterioration].
Orphal J; Terai N
Ophthalmologe; 2021 Jun; 118(6):590-592. PubMed ID: 32642881
[TBL] [Abstract][Full Text] [Related]
30. Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report.
Forryan J; Yong J
J Med Case Rep; 2020 Mar; 14(1):39. PubMed ID: 32127027
[TBL] [Abstract][Full Text] [Related]
31. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.
Molloy ES; Calabrese CM; Calabrese LH
Rheum Dis Clin North Am; 2017 Feb; 43(1):95-109. PubMed ID: 27890176
[TBL] [Abstract][Full Text] [Related]
32. [Progressive multifocal leukoencephalopathy].
Pál E; Aschermann Z; Gömöri E; Kovács GG; Simon G; Maródi L; Komoly S; Illés Z
Ideggyogy Sz; 2007 May; 60(5-6):263-8. PubMed ID: 17578275
[TBL] [Abstract][Full Text] [Related]
33. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
34. A "cortico-basal degeneration"-like syndrome as first sign of progressive multifocal leukoencephalopathy.
Van Zanducke M; Dehaene I
Acta Neurol Belg; 2000 Dec; 100(4):242-5. PubMed ID: 11233680
[TBL] [Abstract][Full Text] [Related]
35. Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features.
Vogrig A; Gigli GL; Nilo A; Pessa ME; Volpetti S; Pegolo E; Valente M
J Neurovirol; 2020 Jun; 26(3):437-441. PubMed ID: 31807988
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments.
Clavel G; Moulignier A; Semerano L
Joint Bone Spine; 2017 Dec; 84(6):671-675. PubMed ID: 28323224
[TBL] [Abstract][Full Text] [Related]
37. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
38. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
Boesl F; Allers K; Herm J; Scheider T; Franke C
J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
[TBL] [Abstract][Full Text] [Related]
39. [Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
Takao M
Brain Nerve; 2013 Nov; 65(11):1363-74. PubMed ID: 24200614
[TBL] [Abstract][Full Text] [Related]
40. Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.
Hadjadj J; Guffroy A; Delavaud C; Taieb G; Meyts I; Fresard A; Streichenberger N; L'Honneur AS; Rozenberg F; D'Aveni M; Aguilar C; Rosain J; Picard C; Mahlaoui N; Lecuit M; Hermine O; Lortholary O; Suarez F
J Clin Immunol; 2019 Jan; 39(1):55-64. PubMed ID: 30552536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
